Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Production of chondroitin in metabolically engineered E. coli
Wenqin He
, Li Fu
, Guoyun Li
, J. Andrew Jones
, Robert J. Linhardt
, Mattheos Koffas
Research output
:
Contribution to journal
›
Article
›
peer-review
134
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Production of chondroitin in metabolically engineered E. coli'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chondroitin
100%
Engineered E. Coli
100%
Chondroitin Sulfate
60%
Pathogenic E. Coli
40%
Multiple Genes
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Gene Expression
20%
Food Chain
20%
Escherichia Coli
20%
Disaccharide Analysis
20%
Metabolic
20%
Similarity Structure
20%
Non-pathogenic
20%
Glycosaminoglycans
20%
Metabolic Engineering
20%
Arthritis
20%
Capsular Polysaccharide
20%
Animal Tissues
20%
Food Animals
20%
Signal Control
20%
NMR Analysis
20%
Shake Flask
20%
Engineered Strain
20%
Dissolved Oxygen
20%
Potential Yield
20%
Gene Addition
20%
Fed-batch Bioreactor
20%
Regulatory Signal
20%
E.coli BL21
20%
Immunology and Microbiology
Escherichia coli
100%
Pathogenic Escherichia Coli
100%
Precursor
50%
Arthritis
50%
Metabolic Engineering
50%
Liquid Chromatography Mass Spectrometry
50%
Animal Tissue
50%
Bioreactor
50%
Dioxygen
50%
Chemistry
Chondroitin Sulfate
100%
Metabolic
66%
Disaccharide
33%
1H NMR Spectroscopy
33%
Liquid Chromatography Mass Spectrometry (LCMS)
33%
Bioreactor
33%
Dioxygen
33%
Polysaccharide
33%
Glycosaminoglycan
33%
Veterinary Science and Veterinary Medicine
Escherichia coli
100%
Chondroitin Sulfate
75%
Arthritis
25%
Food Animal Veterinary Medicine
25%
Glycosaminoglycan
25%